India · Delayed Price · Currency is INR Zydus Lifesciences Statistics
Total Valuation
NSE:ZYDUSLIFE has a market cap or net worth of INR 1.10 trillion. The enterprise value is 1.18 trillion.
| Market Cap | 1.10T |
| Enterprise Value | 1.18T |
Important Dates
The last earnings date was Tuesday, May 19, 2026.
| Earnings Date | May 19, 2026 |
| Ex-Dividend Date | Jul 24, 2026 |
Share Statistics
NSE:ZYDUSLIFE has 1.01 billion shares outstanding. The number of shares has decreased by -0.00% in one year.
| Current Share Class | 1.01B |
| Shares Outstanding | 1.01B |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 75.03% |
| Owned by Institutions (%) | 15.00% |
| Float | 249.56M |
Valuation Ratios
The trailing PE ratio is 21.78 and the forward PE ratio is 26.49. NSE:ZYDUSLIFE's PEG ratio is 3.73.
| PE Ratio | 21.78 |
| Forward PE | 26.49 |
| PS Ratio | 4.04 |
| PB Ratio | 3.71 |
| P/TBV Ratio | 11.32 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 51.88 |
| PEG Ratio | 3.73 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.99, with an EV/FCF ratio of -92.04.
| EV / Earnings | 23.33 |
| EV / Sales | 4.33 |
| EV / EBITDA | 15.99 |
| EV / EBIT | 19.98 |
| EV / FCF | -92.04 |
Financial Position
The company has a current ratio of 1.27, with a Debt / Equity ratio of 0.42.
| Current Ratio | 1.27 |
| Quick Ratio | 0.80 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | 1.72 |
| Debt / FCF | -9.78 |
| Interest Coverage | 13.18 |
Financial Efficiency
Return on equity (ROE) is 18.32% and return on invested capital (ROIC) is 13.47%.
| Return on Equity (ROE) | 18.32% |
| Return on Assets (ROA) | 8.07% |
| Return on Invested Capital (ROIC) | 13.47% |
| Return on Capital Employed (ROCE) | 15.77% |
| Weighted Average Cost of Capital (WACC) | 5.66% |
| Revenue Per Employee | 9.72M |
| Profits Per Employee | 1.81M |
| Employee Count | 27,917 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 1.52 |
Taxes
In the past 12 months, NSE:ZYDUSLIFE has paid 15.95 billion in taxes.
| Income Tax | 15.95B |
| Effective Tax Rate | 23.74% |
Stock Price Statistics
The stock price has increased by +18.28% in the last 52 weeks. The beta is 0.32, so NSE:ZYDUSLIFE's price volatility has been lower than the market average.
| Beta (5Y) | 0.32 |
| 52-Week Price Change | +18.28% |
| 50-Day Moving Average | 942.15 |
| 200-Day Moving Average | 946.78 |
| Relative Strength Index (RSI) | 75.33 |
| Average Volume (20 Days) | 2,414,971 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ZYDUSLIFE had revenue of INR 271.48 billion and earned 50.40 billion in profits. Earnings per share was 50.09.
| Revenue | 271.48B |
| Gross Profit | 198.56B |
| Operating Income | 57.87B |
| Pretax Income | 67.18B |
| Net Income | 50.40B |
| EBITDA | 72.58B |
| EBIT | 57.87B |
| Earnings Per Share (EPS) | 50.09 |
Balance Sheet
The company has 71.92 billion in cash and 124.96 billion in debt, with a net cash position of -53.04 billion or -52.71 per share.
| Cash & Cash Equivalents | 71.92B |
| Total Debt | 124.96B |
| Net Cash | -53.04B |
| Net Cash Per Share | -52.71 |
| Equity (Book Value) | 295.82B |
| Book Value Per Share | 269.52 |
| Working Capital | 41.94B |
Cash Flow
In the last 12 months, operating cash flow was 21.17 billion and capital expenditures -33.94 billion, giving a free cash flow of -12.77 billion.
| Operating Cash Flow | 21.17B |
| Capital Expenditures | -33.94B |
| Depreciation & Amortization | 14.71B |
| Net Borrowing | 72.67B |
| Free Cash Flow | -12.77B |
| FCF Per Share | -12.69 |
Margins
Gross margin is 73.14%, with operating and profit margins of 21.31% and 18.56%.
| Gross Margin | 73.14% |
| Operating Margin | 21.31% |
| Pretax Margin | 24.75% |
| Profit Margin | 18.56% |
| EBITDA Margin | 26.73% |
| EBIT Margin | 21.31% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.09%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 0.09% |
| Dividend Growth (YoY) | -90.91% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 21.95% |
| Buyback Yield | 0.00% |
| Shareholder Yield | 0.10% |
| Earnings Yield | 4.59% |
| FCF Yield | -1.16% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for NSE:ZYDUSLIFE is 1,066.50, which is -2.26% lower than the current price. The consensus rating is "Hold".
| Price Target | 1,066.50 |
| Price Target Difference | -2.26% |
| Analyst Consensus | Hold |
| Analyst Count | 30 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on October 6, 2015. It was a forward split with a ratio of 5.
| Last Split Date | Oct 6, 2015 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |